Drug · DIN 02459949
KYPROLIS
FOR I.V. INFUSION. SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 6, 2017; first marketed February 6, 2017.
- Drug Identification Number (DIN)
- 02459949
- Company (DIN owner)
- Amgen Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Carfilzomib L01XG02
- Class
- Human
- Record last updated
- August 13, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CARFILZOMIB | 30 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 20, 2016: NOC 18796Supplement to a New Drug Submission (SNDS) · New strengths: 10 mg/vial and 30 mg/vial; and updates to the curremntly approved 60 mg/vial presentation
Other DINs named KYPROLIS
- DIN 02451034 · Marketed
- DIN 02459930 · Marketed